Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Mono Vaccine Market by Type (Meningococcal Vaccine, Japanese Encephalitis Vaccine, Yellow Fever Vaccine, Hepatitis Vaccine, Cholera Vaccine, Other), By Application (Adults, Children) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Mono Vaccine Market by Type (Meningococcal Vaccine, Japanese Encephalitis Vaccine, Yellow Fever Vaccine, Hepatitis Vaccine, Cholera Vaccine, Other), By Application (Adults, Children) And By Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 202311 3300 Pharma & Healthcare 377 237 Pages 4.7 (35)
                                          

The global mono vaccine market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing number of vaccines being developed for various diseases and the growing awareness about vaccination among people. Meningococcal Vaccine: The meningococcal vaccine segment accounted for the largest share in 2018 and is expected to continue its dominance throughout the forecast period. This can be attributed to an increase in awareness about meningitis and its prevention, which has led to an increase in demand for this type of vaccine. Japanese Encephalitis Vaccine: The Japanese encephalitis segment accounted for a significant share in 2018 and is expected to grow at a CAGR of 6% during the forecast period, owing mainly due to increased awareness about Japanese encephalitis among people as well as government initiatives towards eradicating it from various regions across Asia Pacific region.

Some Of The Growth Factors Of This Market:

  1. The global population is increasing and the number of people with chronic diseases is also increasing.
  2. The global population is aging, which increases the risk of chronic diseases such as cancer and diabetes.
  3. There are more people living in urban areas than rural areas, which increases the risk of contracting infectious diseases such as influenza and pneumonia due to lack of access to clean water and sanitation facilities in urban areas.
  4. There are more people traveling internationally for business or leisure purposes, which increases the risk of contracting infectious diseases such as influenza and pneumonia due to lack of access to clean water and sanitation facilities in foreign countries.
  5. More children are being vaccinated against infectious disease.

Industry Growth Insights published a new data on “Mono Vaccine Market”. The research report is titled “Mono Vaccine Market research by Types (Meningococcal Vaccine, Japanese Encephalitis Vaccine, Yellow Fever Vaccine, Hepatitis Vaccine, Cholera Vaccine, Other), By Applications (Adults, Children), By Players/Companies GSK, Sanofi Pasteur, Merck, Pfizer, CNBG, Sanofi Pasteur MSD, Serum Institute of India, Biokangtai”.

Scope Of The Report

Report Attributes

Report Details

Report Title

Mono Vaccine Market Research Report

By Type

Meningococcal Vaccine, Japanese Encephalitis Vaccine, Yellow Fever Vaccine, Hepatitis Vaccine, Cholera Vaccine, Other

By Application

Adults, Children

By Companies

GSK, Sanofi Pasteur, Merck, Pfizer, CNBG, Sanofi Pasteur MSD, Serum Institute of India, Biokangtai

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

237

Number of Tables & Figures

166

Customization Available

Yes, the report can be customized as per your need.


Global Mono Vaccine Industry Outlook


Global Mono Vaccine Market Report Segments:

The global Mono Vaccine market is segmented on the basis of:

Types

Meningococcal Vaccine, Japanese Encephalitis Vaccine, Yellow Fever Vaccine, Hepatitis Vaccine, Cholera Vaccine, Other

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Adults, Children

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. GSK
  2. Sanofi Pasteur
  3. Merck
  4. Pfizer
  5. CNBG
  6. Sanofi Pasteur MSD
  7. Serum Institute of India
  8. Biokangtai

Global Mono Vaccine Market Overview


Highlights of The Mono Vaccine Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Meningococcal Vaccine
    2. Japanese Encephalitis Vaccine
    3. Yellow Fever Vaccine
    4. Hepatitis Vaccine
    5. Cholera Vaccine
    6. Other
  1. By Application:

    1. Adults
    2. Children
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Mono Vaccine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Mono Vaccine Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


Mono Vaccine is a vaccine that protects people from mono, a virus that can cause severe respiratory illness. Mono is most commonly spread through coughing and sneezing. The vaccine helps protect against the three types of mono viruses: A (H3N2), B (H1N1), and C (1918 pandemic).

Some of the major players in the mono vaccine market are GSK, Sanofi Pasteur, Merck, Pfizer, CNBG, Sanofi Pasteur MSD, Serum Institute of India, Biokangtai.

The mono vaccine market is expected to grow at a compound annual growth rate of 5.5%.

                                            
1. Executive Summary

2. Assumptions and Acronyms Used

3. Research Methodology

4. Mono Vaccine Market Overview
   4.1. Introduction
      4.1.1. Market Taxonomy
      4.1.2. Market Definition
   4.2. Macro-Economic Factors
      4.2.1. Industry Outlook
   4.3. Mono Vaccine Market Dynamics
      4.3.1. Market Drivers
      4.3.2. Market Restraints
      4.3.3. Opportunity
      4.3.4. Market Trends
   4.4. Mono Vaccine Market - Supply Chain
   4.5. Global Mono Vaccine Market Forecast
      4.5.1. Mono Vaccine Market Size (US$ Mn) and Y-o-Y Growth
      4.5.2. Mono Vaccine Market Size (000’ Units) and Y-o-Y Growth
      4.5.3. Mono Vaccine Market Absolute $ Opportunity

5. Global Mono Vaccine Market Analysis and Forecast by Type
   5.1. Market Trends
   5.2. Introduction
      5.2.1. Basis Point Share (BPS) Analysis by Type
      5.2.2. Y-o-Y Growth Projections by Type
   5.3. Mono Vaccine Market Size and Volume Forecast by Type
      5.3.1. Meningococcal Vaccine
      5.3.2. Japanese Encephalitis Vaccine
      5.3.3. Yellow Fever Vaccine
      5.3.4. Hepatitis Vaccine
      5.3.5. Cholera Vaccine
      5.3.6. Other
   5.4. Absolute $ Opportunity Assessment by Type
   5.5. Market Attractiveness/Growth Potential Analysis by Type

6. Global Mono Vaccine Market Analysis and Forecast by Application
   6.1. Market Trends
   6.2. Introduction
      6.2.1. Basis Point Share (BPS) Analysis by Application
      6.2.2. Y-o-Y Growth Projections by Application
   6.3. Mono Vaccine Market Size and Volume Forecast by Application
      6.3.1. Adults
      6.3.2. Children
   6.4. Absolute $ Opportunity Assessment by Application
   6.5. Market Attractiveness/Growth Potential Analysis by Application

7. Global Mono Vaccine Market Analysis and Forecast by Sales Channel
   7.1. Market Trends
   7.2. Introduction
      7.2.1. Basis Point Share (BPS) Analysis by Sales Channel 
      7.2.2. Y-o-Y Growth Projections by Sales Channel
   7.3. Mono Vaccine Market Size and Volume Forecast by Sales Channel 
      7.3.1. Manufacturer/Distributor/Service Provider
      7.3.2. Aftermarket
   7.4. Absolute $ Opportunity Assessment by Sales Channel
   7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel

8. Global Mono Vaccine Market Analysis and Forecast by Region
   8.1. Market Trends
   8.2. Introduction
      8.2.1. Basis Point Share (BPS) Analysis by Region
      8.2.2. Y-o-Y Growth Projections by Region
   8.3. Mono Vaccine Market Size and Volume Forecast by Region
      8.3.1. North America
      8.3.2. Latin America
      8.3.3. Europe
      8.3.4. Asia Pacific
      8.3.5. Middle East and Africa (MEA)
   8.4. Absolute $ Opportunity Assessment by Region
   8.5. Market Attractiveness/Growth Potential Analysis by Region
   8.6. Global Mono Vaccine Demand Share Forecast, 2019-2026

9. North America Mono Vaccine Market Analysis and Forecast
   9.1. Introduction
      9.1.1. Basis Point Share (BPS) Analysis by Country
      9.1.2. Y-o-Y Growth Projections by Country
   9.2. North America Mono Vaccine Market Size and Volume Forecast by Country
      9.2.1. U.S.
      9.2.2. Canada
   9.3. Absolute $ Opportunity Assessment by Country
   9.4. North America Mono Vaccine Market Size and Volume Forecast by Application
      9.4.1. Adults
      9.4.2. Children
   9.5. Basis Point Share (BPS) Analysis by Application
   9.6. Y-o-Y Growth Projections by Application
   9.7. North America Mono Vaccine Market Size and Volume Forecast by Type
      9.7.1. Meningococcal Vaccine
      9.7.2. Japanese Encephalitis Vaccine
      9.7.3. Yellow Fever Vaccine
      9.7.4. Hepatitis Vaccine
      9.7.5. Cholera Vaccine
      9.7.6. Other
   9.8. Basis Point Share (BPS) Analysis by Type
   9.9. Y-o-Y Growth Projections by Type
   9.10. Market Attractiveness/Growth Potential Analysis
      9.10.1. By Country
      9.10.2. By Product Type
      9.10.3. By Application
      9.10.4. By Sales Channel
   9.11. North America Mono Vaccine Demand Share Forecast, 2019-2026

10. Latin America Mono Vaccine Market Analysis and Forecast
   10.1. Introduction
      10.1.1. Basis Point Share (BPS) Analysis by Country
      10.1.2. Y-o-Y Growth Projections by Country
      10.1.3. Latin America Average Pricing Analysis
   10.2. Latin America Mono Vaccine Market Size and Volume Forecast by Country
      10.2.1. Brazil
      10.2.2. Mexico
      10.2.3. Rest of Latin America
   10.3. Absolute $ Opportunity Assessment by Country
   10.4. Latin America Mono Vaccine Market Size and Volume Forecast by Application
      10.4.1. Adults
      10.4.2. Children
   10.5. Basis Point Share (BPS) Analysis by Application
   10.6. Y-o-Y Growth Projections by Application
   10.7. Latin America Mono Vaccine Market Size and Volume Forecast by Type
      10.7.1. Meningococcal Vaccine
      10.7.2. Japanese Encephalitis Vaccine
      10.7.3. Yellow Fever Vaccine
      10.7.4. Hepatitis Vaccine
      10.7.5. Cholera Vaccine
      10.7.6. Other
   10.8. Basis Point Share (BPS) Analysis by Type
   10.9. Y-o-Y Growth Projections by Type
   10.10. Market Attractiveness/Growth Potential Analysis
      10.10.1. By Country
      10.10.2. By Product Type
      10.10.3. By Application
      10.10.4. By Sales Channel
   10.11. Latin America Mono Vaccine Demand Share Forecast, 2019-2026

11. Europe Mono Vaccine Market Analysis and Forecast
   11.1. Introduction
      11.1.1. Basis Point Share (BPS) Analysis by Country
      11.1.2. Y-o-Y Growth Projections by Country
      11.1.3. Europe Average Pricing Analysis
   11.2. Europe Mono Vaccine Market Size and Volume Forecast by Country
      11.2.1. Germany
      11.2.2. France
      11.2.3. Italy
      11.2.4. U.K.
      11.2.5. Spain
      11.2.6. Russia
      11.2.7. Rest of Europe
   11.3. Absolute $ Opportunity Assessment by Country
   11.4. Europe Mono Vaccine Market Size and Volume Forecast by Application
      11.4.1. Adults
      11.4.2. Children
   11.5. Basis Point Share (BPS) Analysis by Application
   11.6. Y-o-Y Growth Projections by Application
   11.7. Europe Mono Vaccine Market Size and Volume Forecast by Type
      11.7.1. Meningococcal Vaccine
      11.7.2. Japanese Encephalitis Vaccine
      11.7.3. Yellow Fever Vaccine
      11.7.4. Hepatitis Vaccine
      11.7.5. Cholera Vaccine
      11.7.6. Other
   11.8. Basis Point Share (BPS) Analysis by Type
   11.9. Y-o-Y Growth Projections by Type
   11.10. Market Attractiveness/Growth Potential Analysis
      11.10.1. By Country
      11.10.2. By Product Type
      11.10.3. By Application
      11.10.4. By Sales Channel
   11.11. Europe Mono Vaccine Demand Share, 2019-2026

12. Asia Pacific Mono Vaccine Market Analysis and Forecast
   12.1. Introduction
      12.1.1. Basis Point Share (BPS) Analysis by Country
      12.1.2. Y-o-Y Growth Projections by Country
      12.1.3. Asia Pacific Average Pricing Analysis
   12.2. Asia Pacific Mono Vaccine Market Size and Volume Forecast by Country
      12.2.1. China
      12.2.2. Japan
      12.2.3. South Korea
      12.2.4. India
      12.2.5. Australia
      12.2.6. Rest of Asia Pacific (APAC)
   12.3. Absolute $ Opportunity Assessment by Country
   12.4. Asia Pacific Mono Vaccine Market Size and Volume Forecast by Application
      12.4.1. Adults
      12.4.2. Children
   12.5. Basis Point Share (BPS) Analysis by Application
   12.6. Y-o-Y Growth Projections by Application
   12.7. Asia Pacific Mono Vaccine Market Size and Volume Forecast by Type
      12.7.1. Meningococcal Vaccine
      12.7.2. Japanese Encephalitis Vaccine
      12.7.3. Yellow Fever Vaccine
      12.7.4. Hepatitis Vaccine
      12.7.5. Cholera Vaccine
      12.7.6. Other
   12.8. Basis Point Share (BPS) Analysis by Type
   12.9. Y-o-Y Growth Projections by Type
   12.10. Market Attractiveness/Growth Potential Analysis
      12.10.1. By Country
      12.10.2. By Product Type
      12.10.3. By Application
      12.10.4. By Sales Channel
   12.11. Asia Pacific Mono Vaccine Demand Share, 2019-2026

13. Middle East & Africa Mono Vaccine Market Analysis and Forecast
   13.1. Introduction
      13.1.1. Basis Point Share (BPS) Analysis by Country
      13.1.2. Y-o-Y Growth Projections by Country
      13.1.3. Asia Pacific Average Pricing Analysis
   13.2. Middle East & Africa Mono Vaccine Market Size and Volume Forecast by Country
      13.2.1. Saudi Arabia
      13.2.2. South Africa
      13.2.3. UAE
      13.2.4. Rest of Middle East & Africa (MEA)
   13.3. Absolute $ Opportunity Assessment by Country
   13.4. Middle East & Africa Mono Vaccine Market Size and Volume Forecast by Application
      13.4.1. Adults
      13.4.2. Children
   13.5. Basis Point Share (BPS) Analysis by Application
   13.6. Y-o-Y Growth Projections by Application
   13.7. Middle East & Africa Mono Vaccine Market Size and Volume Forecast by Type
      13.7.1. Meningococcal Vaccine
      13.7.2. Japanese Encephalitis Vaccine
      13.7.3. Yellow Fever Vaccine
      13.7.4. Hepatitis Vaccine
      13.7.5. Cholera Vaccine
      13.7.6. Other
   13.8. Basis Point Share (BPS) Analysis by Type
   13.9. Y-o-Y Growth Projections by Type
   13.10. Market Attractiveness/Growth Potential Analysis
      13.10.1. By Country
      13.10.2. By Product Type
      13.10.3. By Application
      13.10.4. By Sales Channel
   13.11. Middle East & Africa Mono Vaccine Demand Share, 2019-2026

14. Competition Landscape
   14.1. Global Mono Vaccine Market: Market Share Analysis
   14.2. Mono Vaccine Distributors and Customers
   14.3. Mono Vaccine Market: Competitive Dashboard
   14.4. Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.4.1. GSK
         14.4.1.1. Overview
         14.4.1.2. Financials
         14.4.1.3. Developments
         14.4.1.4. Strategic Outlook
      14.4.2. Sanofi Pasteur
         14.4.2.1. Overview
         14.4.2.2. Financials
         14.4.2.3. Developments
         14.4.2.4. Strategic Outlook
      14.4.3. Merck
         14.4.3.1. Overview
         14.4.3.2. Financials
         14.4.3.3. Developments
         14.4.3.4. Strategic Outlook
      14.4.4. Pfizer
         14.4.4.1. Overview
         14.4.4.2. Financials
         14.4.4.3. Developments
         14.4.4.4. Strategic Outlook
      14.4.5. CNBG
         14.4.5.1. Overview
         14.4.5.2. Financials
         14.4.5.3. Developments
         14.4.5.4. Strategic Outlook
      14.4.6. Sanofi Pasteur MSD
         14.4.6.1. Overview
         14.4.6.2. Financials
         14.4.6.3. Developments
         14.4.6.4. Strategic Outlook
      14.4.7. Serum Institute of India
         14.4.7.1. Overview
         14.4.7.2. Financials
         14.4.7.3. Developments
         14.4.7.4. Strategic Outlook
      14.4.8. Biokangtai
         14.4.8.1. Overview
         14.4.8.2. Financials
         14.4.8.3. Developments
         14.4.8.4. Strategic Outlook
      14.4.9. COMPANY9
         14.4.9.1. Overview
         14.4.9.2. Financials
         14.4.9.3. Developments
         14.4.9.4. Strategic Outlook
      14.4.10. COMPANY 10
         14.4.10.1. Overview
         14.4.10.2. Financials
         14.4.10.3. Developments
         14.4.10.4. Strategic Outlook
      14.4.11. COMPANY 11
         14.4.11.1. Overview
         14.4.11.2. Financials
         14.4.11.3. Developments
         14.4.11.4. Strategic Outlook
      14.4.12. COMPANY 12
         14.4.12.1. Overview
         14.4.12.2. Financials
         14.4.12.3. Developments
         14.4.12.4. Strategic Outlook
      14.4.13. COMPANY 13
         14.4.13.1. Overview
         14.4.13.2. Financials
         14.4.13.3. Developments
         14.4.13.4. Strategic Outlook
      14.4.14. COMPANY 14
         14.4.14.1. Overview
         14.4.14.2. Financials
         14.4.14.3. Developments
         14.4.14.4. Strategic Outlook
      14.4.15. COMPANY 15
         14.4.15.1. Overview
         14.4.15.2. Financials
         14.4.15.3. Developments
         14.4.15.4. Strategic Outlook
      14.4.16. COMPANY 16
         14.4.16.1. Overview
         14.4.16.2. Financials
         14.4.16.3. Developments
         14.4.16.4. Strategic Outlook
      14.4.17. COMPANY 17
         14.4.17.1. Overview
         14.4.17.2. Financials
         14.4.17.3. Developments
         14.4.17.4. Strategic Outlook
      14.4.18. COMPANY 18
         14.4.18.1. Overview
         14.4.18.2. Financials
         14.4.18.3. Developments
         14.4.18.4. Strategic Outlook
      14.4.19. COMPANY 19
         14.4.19.1. Overview
         14.4.19.2. Financials
         14.4.19.3. Developments
         14.4.19.4. Strategic Outlook
      14.4.20. COMPANY 20
         14.4.20.1. Overview
         14.4.20.2. Financials
         14.4.20.3. Developments
         14.4.20.4. Strategic Outlook

Our Trusted Clients

Contact Us